NCI Events

NCI/NIBIB Synthetic Biology and Cancer Series: Progress and Promise

The National Cancer Institute (NCI) and the National Institute for Biomedical Imaging and Bioengineering (NIBIB) collaboratively launched the Synthetic Biology and Cancer Program in 2021. The goal of the program was to support synthetic biology approaches for cancer research that would expand technology development, promote transdisciplinary partnerships, spur new efforts to advance mechanistic understanding of cancer, and create new possibilities for cancer prevention and management. After five years of progress, the teams will share their discoveries with the broader research community. The Synthetic Biology and Cancer: Progress and Promise Webinar Series invites you to learn about the exciting technical advances in synthetic biology and how they have accelerated cancer research, and explore future directions. The series will occur monthly from June to November 2026.

Trans-NIH Workshop on Micro[nano]plastic Measurement for Population Studies

The 2026 Trans‑NIH Workshop on Micro[nano]plastic Measurement for Population Studies is a two‑day, hybrid meeting taking place July 9- 10, 2026, that will bring together researchers and stakeholders to examine the current state of the science related to micro[nano]plastic (MNP) measurement techniques applicable to population science research, including epidemiologic studies. The workshop will provide a forum for scientific exchange focused on challenges, gaps, and future directions in measuring MNPs in human and environmental samples.

Global Cancer Research and Control Seminar Series

The NCI Center for Global Health’s Global Cancer Research and Control Seminar Series (GCRCSS) features talks by researchers and cancer control experts working in global oncology. The seminars provide opportunities for discussion and collaboration around impactful and innovative work that addresses cancer morbidity and mortality worldwide. 

Summer Omics Nursing Institute

The Summer Omics Nursing Institute will equip nurses with the knowledge, skills, and abilities to develop robust programs of research in symptom science that incorporate molecular omics. Participants will expand their understanding of molecular omic concepts and methods for application in research, teaching, and clinical practice, and will gain the ability to apply these approaches in biobehavioral research. The program will also examine strategies and emerging trends in omic-based therapies and molecular therapeutics, while building critical skills to evaluate the strengths, limitations, and appropriate applications of omic testing, including potential sources of inaccuracy when used in symptom science.

ODS Webinar Series

Webinar sessions focus on data sharing and usage topics including data event outcomes, data sharing and management policies, data sharing guidance, and data sharing processes, tools and resources.

Throughout the year, ODS will host speakers from the cancer research community, which highlight data sharing and usage in the community. If you have topic ideas please contact us at NCIOfficeofDataSharing@mail.nih.gov.

Workshop on Community Engagement to Build Trust in Science and Enhance Environmental Epidemiology Cancer Research

Convened by the National Cancer Institute (NCI), the one day virtual workshop brings together leaders in environmental epidemiology, cancer research, behavioral science, and community engagement to examine how community engagement can reduce cancer risk related to environmental exposures and strengthen trust in science.

Translating Biomolecular Condensates in Cancer: From Discovery to Clinical Application

The National Cancer Institute’s Division of Cancer Treatment and Diagnosis and Division of Cancer Biology are jointly hosting a hybrid workshop to explore how advances in biomolecular condensate biology can be translated into cancer biomarkers, therapeutic targets, and intervention strategies.

Childhood Cancer Data Initiative (CCDI) Annual Symposium

Join the Childhood Cancer Data Initiative (CCDI) Symposium on September 18, 2026, to reflect on our progress and shape what comes next in childhood cancer research. This hybrid event, offered both in person at the National Cancer Institute (NCI) Shady Grove Campus in Rockville, MD, and online, will highlight advances in data infrastructure, showcase AI-driven insights, and explore opportunities to accelerate discovery and improve outcomes for children, adolescents, and young adults.

CPTAC Scientific Symposium Public

The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) are pleased to announce the 2026 CPTAC Scientific Symposium. Join us on September 21, 2026 to learn about the most current advances in the field of cancer proteogenomics and cancer research by our CPTAC investigators. While this meeting is in-person for CPTAC consortium and NIH participants, only virtual option is available for public attendees.

Workshop on Understanding Plasticity and its Role Across the Cancer Continuum

The Workshop on Understanding Plasticity and its Role Across the Cancer Continuum” will be held in a hybrid format, with speakers participating in person and the public attending virtually.

2026 NCI Cohort Consortium Annual Meeting

The 2026 Annual Meeting of the NCI Cohort Consortium will be a hybrid event held on September 24 – 25, 2026. The meeting is sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps, and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.

Fall 2026 NCI Early Drug Development

The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel (e.g., nurses, statisticians, translational scientist, etc.) involved in CTEP funded oncology early drug development. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.

NCI Data Jamboree

The National Cancer Institute (NCI) invites you to participate in the 2026 NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research on November 16-18 at the NIH Neuroscience Building in Rockville, Maryland. The overarching goal is to promote data sharing and use, facilitate interdisciplinary collaborations, and engage and expand the size and scientific diversity of the cancer research community.

DCEG/REB Radiation Epidemiology & Dosimetry Course

The Radiation Epidemiology and Dosimetry Course is conducted periodically by the Radiation Epidemiology Branch of the NCI Division of Cancer Epidemiology and Genetics (DCEG). This course is intended for people who are interested in learning about the health effects of radiation exposure (environmental, occupational, and medical)—particularly the relationship between ionizing radiation and cancer